{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T14:00:03Z","timestamp":1765893603041,"version":"3.48.0"},"reference-count":70,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,12,2]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study was to assess associations between endostatin levels and short-term mortality in unsorted acute hospitalised dyspnoea patients with or without congestive heart failure (CHF), adjusted for common cardiovascular risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting and participants<\/jats:title>\n                    <jats:p>In this prospective observational study, 723 hospitalised patients who visited the emergency department at Sk\u00e5ne University Hospital, Sweden, between 2013 and 2018 were included. Of these, 276 had a history of CHF. The association between endostatin levels and 1 month and 3-month mortality was evaluated, stratified by whether patients had a history of CHF or not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with prior CHF had higher endostatin levels, higher short-term mortality and were more likely to have CHF as discharge diagnosis. In a fully adjusted model, endostatin was independently associated with 3-month mortality (HR=1.01 per 1\u2009ng\/mL increment of endostatin; 95%\u2009CI 1.00 to 1.02; p=0.016). No evidence of association was identified with 1-month mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endostatins are potential biomarkers for 3 months\u2019 mortality in patients hospitalised with CHF seeking emergency care with acute dyspnoea. Further studies are needed in different settings to assess the predictive value of endostatins in patients with CHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-085238","type":"journal-article","created":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T00:05:52Z","timestamp":1736640352000},"page":"e085238","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Association between endostatin and mortality in patients with acute dyspnoea, with or without congestive heart failure: a single-centre, prospective, observational study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6817-5832","authenticated-orcid":false,"given":"Alexander","family":"Yaghoubi","sequence":"first","affiliation":[{"name":"Emergency Department, Sk\u00e5ne University Hospital, Malmo, Sk\u00e5ne, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4276-3797","authenticated-orcid":false,"given":"Caroline","family":"Heijl","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sk\u00e5ne University Hospital, Malm\u00f6, Sk\u00e5ne, Sweden"},{"name":"Department of Clinical Sciences Malm\u00f6, Lund University, Malm\u00f6, Sk\u00e5ne, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3142-4119","authenticated-orcid":false,"given":"Ardavan M","family":"Khoshnood","sequence":"additional","affiliation":[{"name":"Lund University, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5169-2965","authenticated-orcid":false,"given":"Per Erik","family":"W\u00e4ndell","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-0472","authenticated-orcid":false,"given":"Axel C","family":"Carlsson","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Stockholm, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-2240","authenticated-orcid":false,"given":"Torgny","family":"Wessman","sequence":"additional","affiliation":[{"name":"Emergency Department, Sk\u00e5ne University Hospital, Malmo, Sk\u00e5ne, Sweden"},{"name":"Department of Clinical Sciences Malm\u00f6, Lund University, Malm\u00f6, Sk\u00e5ne, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"2025121605560253000_15.1.e085238.1","first-page":"302","article-title":"Prevalence of Dyspnea among Patients Attending the Emergency Department of a Tertiary Care Hospital: A Descriptive Cross-sectional Study","volume":"57","author":"Shrestha","year":"2019","journal-title":"JNMA J Nepal Med Assoc"},{"key":"2025121605560253000_15.1.e085238.2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.emc.2015.08.008","article-title":"Approach to Adult Patients with Acute Dyspnea","volume":"34","author":"DeVos","year":"2016","journal-title":"Emerg Med Clin North Am"},{"key":"2025121605560253000_15.1.e085238.3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MEJ.0000000000000429","article-title":"Signs and symptoms in adult patients with acute dyspnea: a systematic review and meta-analysis","volume":"25","author":"Renier","year":"2018","journal-title":"Eur J Emerg Med"},{"key":"2025121605560253000_15.1.e085238.4","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12878"},{"key":"2025121605560253000_15.1.e085238.5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.emc.2015.08.002","article-title":"Management of Acute Exacerbation of Asthma and Chronic Obstructive Pulmonary Disease in the Emergency Department","volume":"34","author":"Suau","year":"2016","journal-title":"Emerg Med Clin North Am"},{"key":"2025121605560253000_15.1.e085238.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft064"},{"key":"2025121605560253000_15.1.e085238.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl193"},{"key":"2025121605560253000_15.1.e085238.8","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.5.505"},{"key":"2025121605560253000_15.1.e085238.9","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l223","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"key":"2025121605560253000_15.1.e085238.10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-8-16","article-title":"Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study","volume":"8","author":"Karaye","year":"2008","journal-title":"BMC Cardiovasc Disord"},{"key":"2025121605560253000_15.1.e085238.11","doi-asserted-by":"publisher","DOI":"10.1080\/17482940701606913"},{"key":"2025121605560253000_15.1.e085238.12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.23938\/ASSN.0753","article-title":"Prognostic factors on mortality in patients admitted to hospital with heart failure","volume":"43","author":"Valdivia-Marchal","year":"2020","journal-title":"An Sist Sanit Navar"},{"key":"2025121605560253000_15.1.e085238.13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1561-8811(12)80012-5","article-title":"Risk and prognostic factors in patients of heart failure","volume":"2","author":"Jan","year":"2012","journal-title":"J Indian Coll Cardiol"},{"key":"2025121605560253000_15.1.e085238.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81848-6"},{"key":"2025121605560253000_15.1.e085238.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-008-9175-2"},{"key":"2025121605560253000_15.1.e085238.16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2217\/bmm-2017-0025","article-title":"Endostatin: a promising biomarker in the cardiovascular continuum?","volume":"11","author":"Ruge","year":"2017","journal-title":"Biomark Med"},{"key":"2025121605560253000_15.1.e085238.17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/HYPERTENSIONAHA.113.02250","article-title":"Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage","volume":"62","author":"Carlsson","year":"2013","journal-title":"Hypertension"},{"key":"2025121605560253000_15.1.e085238.18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000369076","article-title":"Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts","volume":"40","author":"Ruge","year":"2014","journal-title":"Am J Nephrol"},{"key":"2025121605560253000_15.1.e085238.19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clinbiochem.2019.10.004","article-title":"Endostatin predicts mortality in patients with acute dyspnea - A cohort study of patients seeking care in emergency departments","volume":"75","author":"Carlsson","year":"2020","journal-title":"Clin Biochem"},{"key":"2025121605560253000_15.1.e085238.20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2217\/bmm.14.31","article-title":"Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure","volume":"8","author":"Jungbauer","year":"2014","journal-title":"Biomark Med"},{"key":"2025121605560253000_15.1.e085238.21","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12197"},{"key":"2025121605560253000_15.1.e085238.22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000518221","article-title":"Endostatin in Renal and Cardiovascular Diseases","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis (Basel)"},{"key":"2025121605560253000_15.1.e085238.23","first-page":"448","volume-title":"Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction","volume":"109","author":"Barroso","year":"2017"},{"key":"2025121605560253000_15.1.e085238.24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diabet.2016.03.006","article-title":"The association between endostatin and kidney disease and mortality in patients with type 2 diabetes","volume":"42","author":"Carlsson","year":"2016","journal-title":"Diabetes Metab"},{"key":"2025121605560253000_15.1.e085238.25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/14017431.2018.1483080","article-title":"Circulating endostatin and the incidence of heart failure","volume":"52","author":"Ruge","year":"2018","journal-title":"Scand Cardiovasc J"},{"key":"2025121605560253000_15.1.e085238.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"2025121605560253000_15.1.e085238.27","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.25"},{"key":"2025121605560253000_15.1.e085238.28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.36628\/ijhf.2020.0004","article-title":"Sex and Gender Differences in Heart Failure","volume":"2","author":"Regitz-Zagrosek","year":"2020","journal-title":"Int J Heart Fail"},{"key":"2025121605560253000_15.1.e085238.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2021.10.006"},{"key":"2025121605560253000_15.1.e085238.30","first-page":"1954","volume-title":"Smoking and Heart Failure: A Mendelian Randomization and Mediation Analysis","volume":"8","author":"Lu","year":"2021"},{"key":"2025121605560253000_15.1.e085238.31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/2047487318806658","article-title":"Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies","volume":"26","author":"Aune","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2025121605560253000_15.1.e085238.32","doi-asserted-by":"crossref","first-page":"154910","DOI":"10.1016\/j.metabol.2021.154910","article-title":"Heart failure in diabetes","volume":"125","author":"Jankauskas","year":"2021","journal-title":"Metab Clin Exp"},{"key":"2025121605560253000_15.1.e085238.33","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.699"},{"key":"2025121605560253000_15.1.e085238.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2019.05.007"},{"key":"2025121605560253000_15.1.e085238.35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","article-title":"Hypertension and Heart Failure","volume":"15","author":"Slivnick","year":"2019","journal-title":"Heart Fail Clin"},{"key":"2025121605560253000_15.1.e085238.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2013.10.002"},{"key":"2025121605560253000_15.1.e085238.37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.057444"},{"key":"2025121605560253000_15.1.e085238.38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/cclm-2013-0741","article-title":"The revised Lund-Malm\u00f6 GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population","volume":"52","author":"Nyman","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2025121605560253000_15.1.e085238.39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ndt\/gfad219","article-title":"Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care","volume":"39","author":"Fu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2025121605560253000_15.1.e085238.40","first-page":"11","article-title":"Relative superiority of the revised Lund-Malm\u00f6 equation over 22 other equations used for glomerular filtration rate estimation in undialyzed patients with end-stage renal disease","volume":"132","author":"Zhang","year":"2022","journal-title":"Pol Arch Intern Med"},{"key":"2025121605560253000_15.1.e085238.41","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.14180920"},{"key":"2025121605560253000_15.1.e085238.42","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi631"},{"key":"2025121605560253000_15.1.e085238.43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clon.2008.01.001","article-title":"Recombinant human endostatin-associated acute left heart failure","volume":"20","author":"Jing","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2025121605560253000_15.1.e085238.44","first-page":"930","article-title":"Assessment of the cardiotoxicity of recombinant human endostatin using myocardial biochemical markers in cancer patients","volume":"28","author":"Qin","year":"2008","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2025121605560253000_15.1.e085238.45","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201409-1742OC"},{"key":"2025121605560253000_15.1.e085238.46","doi-asserted-by":"crossref","unstructured":"Xu X , Jiang T , Li Y , et al . Endostatin attenuates heart failure via inhibiting reactive oxygen species in myocardial infarction rats. Biosci Rep 2021;41. doi:10.1042\/BSR20200787","DOI":"10.1042\/BSR20200787"},{"key":"2025121605560253000_15.1.e085238.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203275109"},{"key":"2025121605560253000_15.1.e085238.48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ijcard.2016.03.005","article-title":"Prognostic value of angiopoietin-2 in patients with chronic heart failure","volume":"212","author":"Eleuteri","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025121605560253000_15.1.e085238.49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000368220","article-title":"Predictive value of endostatin in chronic heart failure patients with poor kidney function","volume":"130","author":"Ueland","year":"2015","journal-title":"Cardiology"},{"key":"2025121605560253000_15.1.e085238.50","first-page":"273","article-title":"Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth","volume":"79","author":"O\u2019Reilly","year":"1997","journal-title":"EXS"},{"key":"2025121605560253000_15.1.e085238.51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312921200"},{"key":"2025121605560253000_15.1.e085238.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4827(02)00057-5"},{"key":"2025121605560253000_15.1.e085238.53","doi-asserted-by":"publisher","DOI":"10.1021\/jm0308287"},{"key":"2025121605560253000_15.1.e085238.54","first-page":"5358","article-title":"Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin","volume":"9","author":"Morbidelli","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2025121605560253000_15.1.e085238.55","first-page":"191","article-title":"N-\/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent","volume":"11","author":"Cho","year":"2004","journal-title":"Oncol Rep"},{"key":"2025121605560253000_15.1.e085238.56","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-006-9035-z"},{"key":"2025121605560253000_15.1.e085238.57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.biopha.2016.01.035","article-title":"Endostatin gene therapy inhibits intratumoral macrophage M2 polarization","volume":"79","author":"Foguer","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"2025121605560253000_15.1.e085238.58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188079","article-title":"Basement membrane product, endostatin, as a link between inflammation, coagulation and vascular permeability in COVID-19 and non-COVID-19 acute respiratory distress syndrome","volume":"14","author":"Jandl","year":"2023","journal-title":"Front Immunol"},{"key":"2025121605560253000_15.1.e085238.59","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.038661"},{"key":"2025121605560253000_15.1.e085238.60","doi-asserted-by":"publisher","DOI":"10.1080\/08860220701813335"},{"key":"2025121605560253000_15.1.e085238.61","doi-asserted-by":"crossref","first-page":"296","DOI":"10.20452\/pamw.1079","article-title":"Endostatin and vascular endothelial growth factor: potential regulators of endothelial progenitor cell number in chronic kidney disease","volume":"121","author":"W\u0105torek","year":"2011","journal-title":"Pol Arch Med Wewn"},{"key":"2025121605560253000_15.1.e085238.62","doi-asserted-by":"publisher","DOI":"10.1159\/000336109"},{"key":"2025121605560253000_15.1.e085238.63","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000664"},{"key":"2025121605560253000_15.1.e085238.64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jcm11102896","article-title":"Cardiorenal Syndrome: An Updated Classification Based on Clinical Hallmarks","volume":"11","author":"Pliquett","year":"2022","journal-title":"J Clin Med"},{"key":"2025121605560253000_15.1.e085238.65","doi-asserted-by":"crossref","first-page":"F388","DOI":"10.1152\/ajprenal.00419.2019","article-title":"Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease","volume":"318","author":"Uchida","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"2025121605560253000_15.1.e085238.66","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2021.1983071"},{"key":"2025121605560253000_15.1.e085238.67","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030718","article-title":"Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies","volume":"11","author":"M\u00e9ndez-Vald\u00e9s","year":"2023","journal-title":"Biomedicines"},{"key":"2025121605560253000_15.1.e085238.68","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301704"},{"key":"2025121605560253000_15.1.e085238.69","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2019.11.032","article-title":"Endostatin as a novel prognostic biomarker in acute ischemic stroke","volume":"293","author":"Zhang","year":"2020","journal-title":"Atherosclerosis"},{"key":"2025121605560253000_15.1.e085238.70","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-450","article-title":"External Review and Validation of the Swedish National Inpatient Register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-085238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:56:12Z","timestamp":1765893372000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-085238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,11]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/bmjopen-2024-085238"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-085238","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}